Pharmacokinetics of cefquinome in red-eared slider turtles (Trachemys scripta elegans) after single intravenous and intramuscular injections
Özet
The purpose of this study was to evaluate the pharmacokinetics of cefquinome (CFQ) following single intravenous (IV) or intramuscular (IM) injections of 2 mg/kg body weight in red-eared slider turtles. Plasma concentrations of CFQ were determined by high-performance liquid chromatography and analyzed using noncompartmental methods. The pharmacokinetic parameters following IV injection were as follows: elimination half-life (t1/2λz) 21.73 ± 4.95 hr, volume of distribution at steady-state (Vdss) 0.37 ± 0.11 L/kg, area under the plasma concentration–time curve (AUC0–∞) 163 ± 32 μg hr−1 ml−1, and total body clearance (ClT) 12.66 ± 2.51 ml hr−1 kg−1. The pharmacokinetic parameters after IM injection were as follows: peak plasma concentration (Cmax) 3.94 ± 0.84 μg/ml, time to peak concentration (Tmax) 3 hr, t1/2λz 26.90 ± 4.33 hr, and AUC0–∞ 145 ± 48 μg hr−1 ml−1. The bioavailability after IM injection was 88%. Data suggest that CFQ has a favorable pharmacokinetic profile with a long half-life and a high bioavailability in red-eared slider turtles. Further studies are needed to establish a multiple dosage regimen and evaluate clinical efficacy. © 2017 John Wiley & Sons Ltd
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Uney, K. | |
| dc.contributor.author | Altan, F. | |
| dc.contributor.author | Cetin, G. | |
| dc.contributor.author | Aboubakr, M. | |
| dc.contributor.author | Dik, B. | |
| dc.contributor.author | Sayın, Z. | |
| dc.contributor.author | Er, A. | |
| dc.contributor.author | Elmas, M. | |
| dc.date.accessioned | 2026-10-18T20:29:00.835838642Z | |
| dc.date.available | 2026-10-18T20:29:00.835838642Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | The purpose of this study was to evaluate the pharmacokinetics of cefquinome (CFQ) following single intravenous (IV) or intramuscular (IM) injections of 2 mg/kg body weight in red-eared slider turtles. Plasma concentrations of CFQ were determined by high-performance liquid chromatography and analyzed using noncompartmental methods. The pharmacokinetic parameters following IV injection were as follows: elimination half-life (t1/2λz) 21.73 ± 4.95 hr, volume of distribution at steady-state (Vdss) 0.37 ± 0.11 L/kg, area under the plasma concentration–time curve (AUC0–∞) 163 ± 32 μg hr−1 ml−1, and total body clearance (ClT) 12.66 ± 2.51 ml hr−1 kg−1. The pharmacokinetic parameters after IM injection were as follows: peak plasma concentration (Cmax) 3.94 ± 0.84 μg/ml, time to peak concentration (Tmax) 3 hr, t1/2λz 26.90 ± 4.33 hr, and AUC0–∞ 145 ± 48 μg hr−1 ml−1. The bioavailability after IM injection was 88%. Data suggest that CFQ has a favorable pharmacokinetic profile with a long half-life and a high bioavailability in red-eared slider turtles. Further studies are needed to establish a multiple dosage regimen and evaluate clinical efficacy. © 2017 John Wiley & Sons Ltd | |
| dc.identifier.doi | 10.1111/jvp.12448 | |
| dc.identifier.eissn | 1365-2885 | |
| dc.identifier.endpage | e44 | |
| dc.identifier.issn | 0140-7783 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pmid | 28833214 | |
| dc.identifier.scopus | 2-s2.0-85040036761 | |
| dc.identifier.startpage | e40 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/14224 | |
| dc.identifier.volume | 41 | |
| dc.identifier.wos | WOS:000419403100007 | |
| dc.language.iso | en | |
| dc.publisher | Blackwell Publishing Ltd | |
| dc.relation.ispartof | Journal of Veterinary Pharmacology and Therapeutics | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | cefquinome | |
| dc.subject | pharmacokinetics | |
| dc.subject | red-eared slider turtle | |
| dc.subject | Animals | |
| dc.subject | Anti-Bacterial Agents | |
| dc.subject | Cephalosporins | |
| dc.subject | Half-Life | |
| dc.subject | Injections, Intramuscular | |
| dc.subject | Injections, Intravenous | |
| dc.subject | Turtles | |
| dc.subject | antiinfective agent | |
| dc.subject | cephalosporin derivative | |
| dc.subject | animal experiment | |
| dc.subject | area under the curve | |
| dc.subject | Article | |
| dc.subject | bird | |
| dc.subject | clinical effectiveness | |
| dc.subject | drug absorption | |
| dc.subject | drug bioavailability | |
| dc.subject | drug blood level | |
| dc.subject | drug mechanism | |
| dc.subject | elimination half-life | |
| dc.subject | high performance liquid chromatography | |
| dc.subject | mammal | |
| dc.subject | maximum plasma concentration | |
| dc.subject | nonhuman | |
| dc.subject | plasma clearance | |
| dc.subject | priority journal | |
| dc.subject | single drug dose | |
| dc.subject | time to maximum plasma concentration | |
| dc.title | Pharmacokinetics of cefquinome in red-eared slider turtles (Trachemys scripta elegans) after single intravenous and intramuscular injections | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 9 | |
| rdl.citation.wos | 8 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
